Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer

NCT00307736 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Adenocarcinoma of the Rectum

Interventions

DRUG: 5-fluorouracil
DRUG: bevacizumab
DRUG: erlotinib
PROCEDURE: External beam radiation therapy (EBRT)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]